Previous Chapter Chapter 62: US Markets for Dental Biomaterials Next Chapter
Chapter 62: US Markets for Dental Biomaterials
In 2006, the US market for dental biomaterials exceeded $100 million in revenues. Comprising dental bone graft substitutes (BGS), tissue regeneration (TR) materials, and dental membranes, this market will experience strong growth over the forecast period, driven primarily by the growing number of procedures using dental biomaterials. In the US, dental biomaterials are increasingly used to complement a growing number of dental implant and periodontal procedures. Both procedures are on the rise as a result of increased dentist and patient awareness and demand. This trend is particularly pronounced among the US general practitioner population.